Nephrotic syndrome: PCSK9: A target for hypercholesterolaemia in nephrotic syndrome

Nature Reviews Nephrology

Volumn 12, Issue 9, 2016, Pages 510-

  Morris, Alan W J ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR; PROPROTEIN CONVERTASE SUBTILISIN KEXIN TYPE 9; SERINE PROTEINASE; UNCLASSIFIED DRUG; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PCSK9 PROTEIN, HUMAN; PROPROTEIN CONVERTASE 9;

APOPTOSIS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; HUMAN; HYPERCHOLESTEROLEMIA; NEPHROTIC SYNDROME; NONHUMAN; NOTE; PODOCYTE; PRIORITY JOURNAL; PROTEIN DEGRADATION;

CHOLESTEROL, LDL; HUMANS; HYPERCHOLESTEROLEMIA; NEPHROTIC SYNDROME; PROPROTEIN CONVERTASE 9;

EID: 84978513764     PISSN: 17595061     EISSN: 1759507X     Source Type: Journal    
DOI: 10.1038/nrneph.2016.111     Document Type: Note

References (1)

1. Haas, M. E., et al. The role of proprotein convertase subtilisin/kexin type 9 in nephrotic syndrome-associated hypercholesterolemia. Circulation http://dx.doi. org/10.1161/CIRCULATIONAHA.115.020912 (2016)